Gianturco expandable wire stents in the treatment of superior vena cava syndrome recurring after maximum-tolerance radiation

Rösch, Josef; Bedell, Jane E.; Putnam, J S; Antonovic, Ruza; Uchida, Barry T.

doi:10.1002/1097-0142(19870915)60:6<1243::aid-cncr2820600614>3.0.co;2-5

Cited by 88 publications

(26 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition to use in the larger pelvic and femoral arteries, stents are now also implanted in the arteries of the lower leg. As a result of the success of stents in arteries, they have also been used in venous stenoses initially in animal experiments and later in humans [5,6].…”

Section: Materials and Methods From January 2003 To Novembermentioning

confidence: 99%

Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause

Büstgens

Loose

Ficker

et al. 2017

Fortschr Röntgenstr

View full text Add to dashboard Cite

Purpose?The purpose of this paper is the retrospective analysis of endovascular therapy for the treatment of superior vena cava syndrome (SVCS) of malignant cause. This study focuses on the effectiveness of the therapy regarding the duration of remission, symptom control and practicability. Materials and Methods?From January 2003 to November 2012, therapeutic implantation of one or more stents was performed in 141 patients suffering from SVCS.?The medical history was retrospectively researched using digitalized patient files. If those were incomplete, secondary research was conducted using the cancer registry of the General Hospital Nuremberg, the cancer registry of the tumor center at Friedrich-Alexander-University Erlangen-Nuremberg (FAU) or information given by physicians in private practice. This data was collected using Microsoft Office Excel? and statistically analyzed using IBM SPSS Statistics 22?. Results?168 stents were implanted in 141 patients (median age: 64.6?years; range: 36???84), 86 being male and 55 being female. In 121 patients, SVCS was caused by lung cancer (85.8?%), in 9 patients by mediastinal metastasis of an extrathoracic carcinoma (6.4?%), in 3?patients by mesothelioma of the pleura (2.1?%) and in 1 patient by Hodgkin?s disease (0.7?%). There was no histological diagnosis in 7?cases (4.9?%). The primary intervention was successful in 138 patients (97.9?%). Immediate thrombosis in the stent occurred in the remaining 3 cases. Recurrence of SVCS was observed in 22 patients (15.6?%), including 5 early and 17 late occlusions. Stent dislocation or?breakage was not observed. As expected, the survival after implantation was poor. The median survival was 101 days, and the median occlusion-free survival was 80 days. Conclusion?The symptomatic therapy of SVCS with endovascular stents is effective and safe. Despite effective symptom control and a low rate of recurrence, the patients' prognosis is poor. Key Points:? Citation Format

show abstract

Section: Materials and Methods From January 2003 To Novembermentioning

confidence: 99%

Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause

Büstgens

Loose

Ficker

et al. 2017

Fortschr Röntgenstr

View full text Add to dashboard Cite

show abstract

“…The introduction of expandable metal vascular stents further broadened the spectrum of closed minimally invasive techniques in the chest, allowing for minimally invasive treatment of superior vena cava (SVC) obstruction with an immediate clinical result [13]. The most prominent interventional radiological techniques in the chest mentioned earlier will be discussed in this paper.…”

mentioning

confidence: 99%

Imaging guided thoracic interventions

Ghaye¹,

Dondelinger²

2001

Eur Respir J

View full text Add to dashboard Cite

Interventional Radiology is a technique based medical specialty, using all available imaging modalities (¯uoroscopy, ultrasound, computed tomography, magnetic resonance, angiography) for guidance of interventional techniques for diagnostic or therapeutic purposes.Actual, percutaneous transthoracic needle biopsy includes core needle biopsy besides ®ne needle aspiration. Any pleural, pulmonary or mediastinal¯uid or gas collection is amenable to percutaneous pulmonary catheter drainage.Treatment of haemoptysis of the bronchial artery or pulmonary artery origin, transcatheter embolization of pulmonary arteriovenous malformations and pseudoaneurysms, angioplasty and stenting of the superior vena caval system and percutaneous foreign body retrieval are well established routine procedures, precluding unnecessary surgery. These techniques are safe and effective in experienced hands.Computed tomography is helpful in pre-and postoperative imaging of patients being considered for endobronchial stenting. Many procedures can be performed on an outpatient basis, thus increasing the cost-effectiveness of radiologically guided interventions in the thorax.

show abstract

“…(27)(28)(29)(30)(31)(32) Regardless of the type of stent used, immediate relief of symptoms such as headache has been reported by various authors. Cyanosis and facial edema improve in one or two days, (31)(32)(33)(34) and edema of the upper limbs is generally resolved two or three days after the insertion of the stent (23,30,34) but can persist for up to one week.…”

Section: Clinical Resultsmentioning

confidence: 99%

“…The authors observed immediate relief of the obstructive symptoms, as well as a favorable palliative result in the short-term (six months), in both patients. (31) In fact, prior to that study, the Gianturco stent had been used in the treatment of SVCS by other authors (in 1986). However, in that previous study, the patient died (as a result of chemotherapy toxicity) three weeks after stent placement.…”

Section: Clinical Resultsmentioning

confidence: 99%

“…In two different studies, thrombosis occurred (one case in each study) soon after the placement of the stent in the superior vena cava in patients who had not been submitted to anticoagulation. (29,31) The recurrence of SVCS can be treated using interventional radiological techniques. Thrombolysis, angioplasty, and the placement of an additional stent have been reportedly used as successful treatment modalities in cases of recurrence.…”

Section: Clinical Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Tratamento da síndrome da veia cava superior

et al. 2005

View full text Add to dashboard Cite

The superior vena cava is formed by the union of the right and left brachiocephalic veins. It is located in the middle mediastinum, to the right of the aorta and anterior to the trachea. Superior vena cava syndrome consists of a group of signs (dilation of the veins in the neck, facial swelling, edema of the upper limbs, and cyanosis) and symptoms (headache, dyspnea, cough, orthopnea and dysphagia) caused by the obstruction of blood flow through the superior vena cava to the right atrium. This obstruction can be caused by extrinsic compression, tumor invasion or thrombosis. Such obstruction may also occur as a result of insufficient venous return secondary to intra-atrial or intraluminal diseases. From 73% to 93% of all cases of superior vena cava syndrome occur during the development of an intrathoracic tumor. Most patients presenting superior vena cava syndrome secondary to malignant neoplasms are treated without surgery, through radiotherapy, chemotherapy or the use of intraluminal stents. When the etiology of superior vena cava syndrome is benign, it can be treated with clinical measures (anticoagulation, raising the head, etc.) or, in refractory cases, with angioplasty, stents or surgery.

show abstract

Gianturco expandable wire stents in the treatment of superior vena cava syndrome recurring after maximum-tolerance radiation

Cited by 88 publications

References 5 publications

Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause

Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause

Imaging guided thoracic interventions

Tratamento da síndrome da veia cava superior

Contact Info

Product

Resources

About